SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-19-040442
Filing Date
2019-08-16
Accepted
2019-08-16 17:17:45
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tv527219_s3.htm S-3 182621
2 EXHIBIT 5.1 tv527219_ex5-1.htm EX-5.1 6125
3 EXHIBIT 23.1 tv527219_ex23-1.htm EX-23.1 3800
  Complete submission text file 0001144204-19-040442.txt   193878
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-233349 | Film No.: 191034205
SIC: 2836 Biological Products, (No Diagnostic Substances)